A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.
By Xiao-Jun Ma, Zuncai Wang, P. Ryan, S. Isakoff, A. Barmettler, Andrew Fuller, Beth Muir, G. Mohapatra, R. Salunga, J. Tuggle and 20 more. Cancer Cell, 2004
983 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Oncology
View Paper: https://www.semanticscholar.org/paper/26887a17ef00fc2a6b58d931b821c48d5160f4a1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Bert Vogelstein
- Kenneth W. Kinzler
- Kenta Nakai
- Akinori Sarai
- Robert Tibshirani
- Trevor J. Hastie
- Purvesh Khatri
- Ian O. Ellis
In Genetics
- Robert Tibshirani
- Trevor J. Hastie
- Mauro Delorenzi
- Purvesh Khatri
- Jerome H. Friedman
- Nuno L. Barbosa-Morais
- A. Cano
- Sorin Draghici
In Oncology
- A. Cano
- G. Moreno-Bueno
- Bert Vogelstein
- Kenneth W. Kinzler
- F. Portillo
- M. Nieto
- R. Weinberg
- Thomas Brabletz
Citations in the corpus
- Reliability and reproducibility issues in DNA microarray measurements. (2006, background): “Studies based on expression profiling of human cancer samples with various clinical outcomes usually produce gene-expression classifiers involving ten to 100 genes [4,5,57–59], although microarray-based classifiers with as few as two genes have also been published [60, 61 ].”
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients (2012, methodology): “Using a publically available gene expression array dataset [GenBank:GDS806] [22] from NCBI Gene Expression Omnibus profiles [23] we were able to identify that breast cancer patients receiving endocrine therapy, who had recurrence, had significantly higher gene expression levels of CD68 (Figure 3B).”
- The transcriptional repressor Snail promotes mammary tumor recurrence. (2005, background): “204 receptor-positive breast cancers from patients without distant metastases at the time of tumor resection (Ma et al., 2004).”
- Breast cancer metastasis: markers and models (2005, background): “showed that the expression ratio of the two genes HIXB13 and IL17BL accurately predicts metastatis developmen”
- A Sparse-Group Lasso (2013, methodology): “The second dataset we used for comparison was the breast cancer data by Ma et al. (2004).”
- PrognoScan: a new database for meta-analysis of the prognostic value of genes (2009, background): “As of February 2009, the collection included more than 40 datasets of various cancer types spanning a wide range of cancers including bladder, blood, breast, brain, esophagus, head and neck, kidney, lung, and ovarian (Table 1) [10-35], far more comprehensive than both ITTACA, which focuses on bladde”
- Transcriptional regulation of cell polarity in EMT and cancer (2008, background): “The correlation between the transcription factors and polarity genes indicated was reinforced by the identification of 9, 11 and 8 canonical E-boxes in the promoter region of the DLG3, LLGL2 and PARD6A genes, respectively.”